Actinium Pharmaceuticals, Inc. (ATNM)
1.45
+0.03
(+2.11%)
USD |
NYAM |
Dec 11, 16:00
1.50
+0.05
(+3.45%)
Pre-Market: 09:03
Actinium Pharmaceuticals Research and Development Expense (TTM): 20.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Arcus Biosciences, Inc. | 503.00M |
| Apyx Medical Corp. | 3.546M |
| AbbVie, Inc. | 8.815B |
| Karyopharm Therapeutics, Inc. | 130.89M |
| NovaBay Pharmaceuticals, Inc. | -- |